Heart failure: clinical trials update 2022
EPR rounds up results from several key clinical trials on therapies for hypertension and heart failure presented at the American Heart Association’s Scientific Sessions 2022.
List view / Grid view
EPR rounds up results from several key clinical trials on therapies for hypertension and heart failure presented at the American Heart Association’s Scientific Sessions 2022.
Hypertension drug-resistance could no longer be a problem for patients, according to a study on Baxdrostat, shown to lower blood pressure.
The ‘new’ test is one currently used in Europe, however the US Food and Drug Administration have recently given approval for the high-sensitivity troponin test...
National Institutes of Health (NIH) funding to conduct cardiac arrest research has dwindled in the last decade and is a fraction of government spend...